标题
Kinase inhibitors and monoclonal antibodies in oncology: clinical implications
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 13, Issue 4, Pages 209-227
出版商
Springer Nature
发表日期
2015-12-31
DOI
10.1038/nrclinonc.2015.213
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeted agents for cancer treatment during pregnancy
- (2015) Matteo Lambertini et al. CANCER TREATMENT REVIEWS
- The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis
- (2015) Friedrich Grimminger et al. EUROPEAN RESPIRATORY JOURNAL
- Has Hospice Use Changed? 2000–2010 Utilization Patterns
- (2015) Melissa D. Aldridge et al. MEDICAL CARE
- Drugs, cancer and end-of-life care: A case study of pharmaceuticalization?
- (2015) Courtney Davis SOCIAL SCIENCE & MEDICINE
- Clinical Observations on Associations Between the UGT1A1 Genotype and Severe Toxicity of Irinotecan
- (2014) Yan-Yan Lu et al. Asian Pacific Journal of Cancer Prevention
- Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)
- (2014) Jai N. Patel et al. CANCER
- Safety and efficacy of addition of VEGFR and EGFR-family oral small-molecule tyrosine kinase inhibitors to cytotoxic chemotherapy in solid cancers: A systematic review and meta-analysis of randomized controlled trials
- (2014) Tomohiro Funakoshi et al. CANCER TREATMENT REVIEWS
- Managing treatment–related adverse events associated with Alk inhibitors
- (2014) J.M. Rothenstein et al. Current Oncology
- Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors
- (2014) V. Hirsh et al. Current Oncology
- Effect of Tyrosine Kinase Inhibitors on Wound Healing and Tissue Repair: Implications for Surgery in Cancer Patients
- (2014) Devron R. Shah et al. DRUG SAFETY
- Review of therapeutic drug monitoring of anticancer drugs part two – Targeted therapies
- (2014) Nicolas Widmer et al. EUROPEAN JOURNAL OF CANCER
- Association Between the Medicare Hospice Benefit and Health Care Utilization and Costs for Patients With Poor-Prognosis Cancer
- (2014) Ziad Obermeyer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk of interstitial lung disease associated with EGFR-TKIs in advanced non-small-cell lung cancer: a meta-analysis of 24 phase III clinical trials
- (2014) Wei-Xiang Qi et al. JOURNAL OF CHEMOTHERAPY
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- (2014) L. Vanneste et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dermatologic adverse events to chemotherapeutic agents, Part 1: cytotoxic agents, epidermal growth factor inhibitors, multikinase inhibitors, and proteasome inhibitors
- (2014) Rachel Kyllo et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Risk of hypothyroidism in patients with cancer treated with sunitinib: A systematic review and meta-analysis
- (2013) Tomohiro Funakoshi et al. ACTA ONCOLOGICA
- Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral Clinic
- (2013) Alyx C. Rosen et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- (2013) Grace K. Dy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Heart rate decrease during crizotinib treatment and potential correlation to clinical response
- (2013) Sai-Hong Ignatius Ou et al. CANCER
- Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch
- (2013) Brian A. Baldo et al. CANCER AND METASTASIS REVIEWS
- Venous thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A systematic review and meta-analysis of randomized clinical trials
- (2013) Guru Sonpavde et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Skin Cancer Associated With the Use of Sorafenib and Sunitinib for Renal Cell Carcinoma
- (2013) Kathryn Breaker et al. DERMATOLOGIC SURGERY
- Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)
- (2013) Rashmi R. Shah et al. DRUG SAFETY
- Ocular adverse events of molecularly targeted agents approved in solid tumours: A systematic review
- (2013) Olivier Huillard et al. EUROPEAN JOURNAL OF CANCER
- Hospices’ Enrollment Policies May Contribute To Underuse Of Hospice Care In The United States
- (2013) Melissa D. Aldridge Carlson et al. HEALTH AFFAIRS
- Change in End-of-Life Care for Medicare Beneficiaries
- (2013) Joan M. Teno et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- End-of-Life Care Discussions in Patients With Advanced Cancer
- (2013) Pallavi Kumar et al. JOURNAL OF CLINICAL ONCOLOGY
- Pruritus in patients treated with targeted cancer therapies: Systematic review and meta-analysis
- (2013) Courtney J. Ensslin et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
- (2012) H. J. Khoury et al. BLOOD
- Cardiac Toxicity of Targeted Therapies Used in the Treatment for Solid Tumours: A Review
- (2012) Marek Svoboda et al. Cardiovascular Toxicology
- Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
- (2012) David Montani et al. CIRCULATION
- Tyrosine kinase inhibitors and drug interactions: a review with practical recommendations
- (2012) Bella Pajares et al. Clinical & Translational Oncology
- Onco-Nephrology: Renal Toxicities of Chemotherapeutic Agents
- (2012) M. A. Perazella Clinical Journal of the American Society of Nephrology
- The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs
- (2012) Saroj Niraula et al. JOURNAL OF CLINICAL ONCOLOGY
- Ocular Toxicity of Targeted Therapies
- (2012) Daniel J. Renouf et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted Agent Use in Cancer Patients at the End of Life
- (2012) David Hui et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Targeted Therapy at the End of Life in Advanced Cancer Patients
- (2012) Thomas I. Peng Soh et al. JOURNAL OF PALLIATIVE MEDICINE
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Folliculitis Induced by EGFR Inhibitors, Preventive and Curative Efficacy of Tetracyclines in the Management and Incidence Rates According to the Type of EGFR Inhibitor Administered: A Systematic Literature Review
- (2012) J.-B. Bachet et al. ONCOLOGIST
- Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab
- (2011) D. Lenihan et al. ANNALS OF ONCOLOGY
- Economic Burden of Dermatologic Adverse Events Induced by Molecularly Targeted Cancer Agents
- (2011) Judy H. Borovicka ARCHIVES OF DERMATOLOGY
- Recommendations on management of EGFR inhibitor-induced skin toxicity: A systematic review
- (2011) J.M. Baas et al. CANCER TREATMENT REVIEWS
- Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy
- (2011) Dongho Kim et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Sunitinib-Induced Hypothyroidism Is due to Induction of Type 3 Deiodinase Activity and Thyroidal Capillary Regression
- (2011) Mariëtte H. W. Kappers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tyrosine Kinase Inhibitors Noncompetitively Inhibit MCT8-Mediated Iodothyronine Transport
- (2011) Doreen Braun et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oncogenic Targets, Magnitude of Benefit, and Market Pricing of Antineoplastic Drugs
- (2011) Eitan Amir et al. JOURNAL OF CLINICAL ONCOLOGY
- Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies
- (2011) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Asymptomatic Profound Sinus Bradycardia (Heart Rate ≤45) in Non-small Cell Lung Cancer Patients Treated with Crizotinib
- (2011) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hematologic toxicities of small molecule tyrosine kinase inhibitors
- (2011) Nicholas A. Barber et al. Targeted Oncology
- Pulmonary toxicities from targeted therapies: a review
- (2011) Nicholas A. Barber et al. Targeted Oncology
- Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC)
- (2011) Lauren C. Harshman et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The effect on survival of continuing chemotherapy to near death
- (2011) Akiko M Saito et al. BMC Palliative Care
- Costs of hospital events in patients with metastatic colorectal cancer
- (2011) Jetty A. Overbeek et al. JOURNAL OF MEDICAL ECONOMICS
- Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes
- (2010) F. A. B. Schutz et al. ANNALS OF ONCOLOGY
- Recall pneumonitis during systemic treatment with sunitinib
- (2010) C. Seidel et al. ANNALS OF ONCOLOGY
- Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy
- (2010) M. Johannsen et al. ANNALS OF ONCOLOGY
- The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma
- (2010) N Shinohara et al. BRITISH JOURNAL OF CANCER
- Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life
- (2010) Smita S. Joshi et al. CANCER
- Risk of cardiac dysfunction with trastuzumab in breast cancer patients: A meta-analysis
- (2010) Tao Chen et al. CANCER TREATMENT REVIEWS
- Meta-Analysis of Incidence and Risk of Hypomagnesemia with Cetuximab for Advanced Cancer
- (2010) Yunfei Cao et al. CHEMOTHERAPY
- Value and Cancer Care: Toward an Equitable Future
- (2010) L. E. Schnipper et al. CLINICAL CANCER RESEARCH
- Biologically Targeted Cancer Therapy and Marginal Benefits: Are We Making Too Much of Too Little or Are We Achieving Too Little by Giving Too Much?
- (2010) T. Fojo et al. CLINICAL CANCER RESEARCH
- Thromboembolic Events in Patients Treated with Anti-Angiogenic Drugs
- (2010) Patrizia Ferroni et al. Current Vascular Pharmacology
- Targeted molecular therapies (cetuximab and bevacizumab) do not induce additional hepatotoxicity: Preliminary results of a case–control study
- (2010) P. Pessaux et al. EJSO
- Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinoma
- (2010) Shuichi Sato et al. ENDOCRINE JOURNAL
- Sorafenib-Induced Hypothyroidism Is Associated with Increased Type 3 Deiodination
- (2010) Randa M. Abdulrahman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Place of Death: Correlations With Quality of Life of Patients With Cancer and Predictors of Bereaved Caregivers' Mental Health
- (2010) Alexi A. Wright et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
- (2010) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of the Patient Care Monitor (Version 2.0): A Review of System Assessment Instrument for Cancer Patients
- (2010) Amy P. Abernethy et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Targeted Therapy at the End of Life for Patients with Lung Cancer
- (2010) Alvin S. Wong et al. JOURNAL OF PALLIATIVE MEDICINE
- Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer
- (2010) P. A. Bradbury et al. JNCI-Journal of the National Cancer Institute
- Understanding and circumventing resistance to anticancer monoclonal antibodies
- (2010) Lina Reslan et al. mAbs
- Electronic Patient-Reported Data Capture as a Foundation of Rapid Learning Cancer Care
- (2010) Amy P. Abernethy et al. MEDICAL CARE
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
- (2010) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sunitinib Induces Hypothyroidism with a Markedly Reduced Vascularity
- (2010) Noriko Makita et al. THYROID
- Severe bronchospasm associated with rituximab for refractory Churg-Strauss syndrome
- (2009) M-A Bouldouyre et al. ANNALS OF THE RHEUMATIC DISEASES
- Pulmonary toxicities of biologics: a review
- (2009) Maajid Mumtaz Peerzada et al. ANTI-CANCER DRUGS
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- (2009) Jorg Hartmann et al. CURRENT DRUG METABOLISM
- Skin toxicities of targeted therapies
- (2009) Siegfried Segaert et al. EUROPEAN JOURNAL OF CANCER
- VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management
- (2009) Hassane Izzedine et al. EUROPEAN JOURNAL OF CANCER
- Risk of Venous Thromboembolism With Bevacizumab in Cancer Patients—Reply
- (2009) David Chu JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Keratoacanthomas and Squamous Cell Carcinomas in Patients Receiving Sorafenib
- (2009) Jean Philippe Arnault et al. JOURNAL OF CLINICAL ONCOLOGY
- Incremental Advance or Seismic Shift? The Need to Raise the Bar of Efficacy for Drug Approval
- (2009) Alberto Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
- (2009) Neal J. Meropol et al. JOURNAL OF CLINICAL ONCOLOGY
- U.S. Hospice Benefits
- (2009) Stephen R. Connor JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion Question
- (2009) T. Fojo et al. JNCI-Journal of the National Cancer Institute
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
- (2009) Adriana Albini et al. JNCI-Journal of the National Cancer Institute
- Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials
- (2009) Edith A. Perez et al. MAYO CLINIC PROCEEDINGS
- Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy
- (2009) Francesco Torino et al. Nature Reviews Clinical Oncology
- Neurological adverse effects caused by cytotoxic and targeted therapies
- (2009) David Schiff et al. Nature Reviews Clinical Oncology
- Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib
- (2009) Adam D. Lipworth et al. ONCOLOGY
- Clinical Predictors of Severe Cetuximab-Induced Rash: Observations from 933 Patients Enrolled in North Central Cancer Treatment Group Study N0147
- (2009) Aminah Jatoi et al. ONCOLOGY
- Renal toxicity of targeted therapies
- (2009) Ronan J. Kelly et al. Targeted Oncology
- Cardiac dysfunction induced by novel targeted anticancer therapy: An emerging issue
- (2009) Ming Hui Chen Current Cardiology Reports
- Chemotherapy-induced diarrhoea
- (2009) Rachel J Gibson et al. Current Opinion in Supportive and Palliative Care
- Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
- (2009) Alexander Stein et al. Therapeutic Advances in Medical Oncology
- Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features
- (2008) W.S. Bartynski AMERICAN JOURNAL OF NEURORADIOLOGY
- Trastuzumab-Induced Hepatotoxicity
- (2008) Sridhar Srinivasan et al. ANNALS OF PHARMACOTHERAPY
- Hypertension and proteinuria: a class-effect of antiangiogenic therapies
- (2008) Vincent Launay-Vacher et al. ANTI-CANCER DRUGS
- The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation
- (2008) P Wolter et al. BRITISH JOURNAL OF CANCER
- Diffuse Alveolar Hemorrhage Following Alemtuzumab
- (2008) Ashutosh Sachdeva et al. CHEST
- Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
- (2008) Ming Hui Chen et al. CIRCULATION
- A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer
- (2008) W. L. Dahut et al. CLINICAL CANCER RESEARCH
- Thyrotoxicosis during sunitinib treatment for renal cell carcinoma
- (2008) Mathis Grossmann et al. CLINICAL ENDOCRINOLOGY
- Editorial [Hot Topic: Therapeutic Antibodies and Derivatives: From the Bench to the Clinic(Guest Editor: Alain Beck)]
- (2008) A. Beck et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis
- (2008) Manfred Johannsen et al. EUROPEAN UROLOGY
- Recurrent Gefitinib-induced Interstitial Lung Disease
- (2008) Masaru Suzuki et al. INTERNAL MEDICINE
- Reversible posterior leucoencephalopathy syndrome associated with anticancer drugs
- (2008) M. A. Marinella et al. INTERNAL MEDICINE JOURNAL
- Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients
- (2008) Shobha Rani Nalluri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia
- (2008) Neil P. Shah et al. JOURNAL OF CLINICAL ONCOLOGY
- Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress
- (2008) Robert K. Oldham et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?
- (2008) Craig C. Earle et al. JOURNAL OF CLINICAL ONCOLOGY
- The Terrible Choice: Re-Evaluating Hospice Eligibility Criteria for Cancer
- (2008) David J. Casarett et al. JOURNAL OF CLINICAL ONCOLOGY
- Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib
- (2008) G. Bollee et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- VEGF Inhibition and Renal Thrombotic Microangiopathy
- (2008) Vera Eremina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reversible posterior leukoencephalopathy syndrome in cancer
- (2008) Christopher Vaughn et al. Current Oncology Reports
- Drug Insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy
- (2008) Yohann Loriot et al. Nature clinical practice. Oncology
- Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs
- (2007) Ravi V. J. Chari ACCOUNTS OF CHEMICAL RESEARCH
- Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib
- (2007) I. Tamaskar et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search